Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,610 | -42,942 | -40,855 | -16,919 | -14,847 |
| Depreciation Amortization | 1,217 | 709 | 233 | 5 | 16 |
| Accounts payable and accrued liabilities | -5,298 | 5,764 | -90 | -106 | 218 |
| Other Working Capital | -5,752 | -199 | 4,475 | 76 | 1,568 |
| Other Operating Activity | 12,413 | 3,033 | 10,527 | 4,457 | -103 |
| Operating Cash Flow | $-35,030 | $-33,636 | $-25,710 | $-12,486 | $-13,149 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-29 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 25,000 | N/A | N/A |
| Debt Repayment | -3,181 | -59 | N/A | N/A | N/A |
| Common Stock Issued | 23,369 | 16,436 | 10,008 | 48,889 | 29,827 |
| Other Financing Activity | 0 | 0 | -720 | 0 | 0 |
| Financing Cash Flow | $20,188 | $16,377 | $34,287 | $48,889 | $29,827 |
| Beginning Cash Position | 56,561 | 73,820 | 65,243 | 28,840 | 12,162 |
| End Cash Position | 41,690 | 56,561 | 73,820 | 65,243 | 28,840 |
| Net Cash Flow | $-14,871 | $-17,260 | $8,578 | $36,403 | $16,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,030 | -33,636 | -25,710 | -12,486 | -13,149 |
| Capital Expenditure | -29 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -35,059 | -33,636 | -25,710 | -12,486 | -13,149 |